Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
Mate Maus,Vanessa López-Polo,Lidia Mateo,Miguel Lafarga,Mònica Aguilera,Eugenia De Lama,Kathleen Meyer,Anna Sola,Cecilia Lopez-Martinez,Ines López-Alonso,Marc Guasch-Piqueras,Fernanda Hernandez-Gonzalez,Selim Chaib,Miguel Rovira,Mayka Sanchez,Rosa Faner,Alvar Agusti,Rodrigo Diéguez-Hurtado,Sagrario Ortega,Anna Manonelles,Stefan Engelhardt,Freddy Monteiro,Camille Stephan-Otto Attolini,Neus Prats,Guillermo Albaiceta,Josep M Cruzado,Manuel Serrano
DOI: https://doi.org/10.1038/s42255-023-00928-2
Abstract:Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron. We show that vascular and hemolytic injuries are efficient in triggering iron accumulation, which in turn can cause senescence and promote fibrosis. Notably, we find that senescent cells persistently accumulate iron, even when the surge of extracellular iron has subdued. Indeed, under normal conditions of extracellular iron, cells exposed to different types of senescence-inducing insults accumulate abundant ferritin-bound iron, mostly within lysosomes, and present high levels of labile iron, which fuels the generation of reactive oxygen species and the SASP. Finally, we demonstrate that detection of iron by magnetic resonance imaging might allow non-invasive assessment of fibrotic burden in the kidneys of mice and in patients with renal fibrosis. Our findings suggest that iron accumulation plays a central role in senescence and fibrosis, even when the initiating events may be independent of iron, and identify iron metabolism as a potential therapeutic target for senescence-associated diseases.